Results 181 to 190 of about 33,479 (238)

Stage-Dependent Efficacy of TACE Combined with Tyrosine Kinase and Immune Checkpoint Inhibitors as Conversion Therapy for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study. [PDF]

J Hepatocell Carcinoma
Zhou H, Ye L, Yue W, Lin K, Chi B, Liao J, Chen X, Shi H, Wang T, Jiang Z, Luo J, Huang B, Yu Y, He Q.   +13 more
europepmc   +1 more source

Bronchial Arterial Chemoembolization with versus without Anlotinib in Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Case-Control Study. [PDF]

Clin Interv Aging
Lai L, Si T, Yao H, Gong S, Duan X, Jin ZC, Zhang D, Ji J, Tu J.   +8 more
europepmc   +1 more source

DEB-TACE-HAIC combined with donafenib and camrelizumab in the treatment of unresectable hepatocellular carcinoma: a multicenter retrospective study. [PDF]

Front Immunol
Ma Y, Long J, Shi S, Fang X, Wang R, Xiong F, Ren H, Li W, Zhang X.   +8 more
europepmc   +1 more source

Analysis of risk factors and prediction of prognosis in patients with primary liver cancer undergoing transarterial chemoembolization. [PDF]

Front Oncol
Lu XL, Yin LM.
europepmc   +1 more source

Efficacy of PD-1/PD-L1 inhibitors combined with anti-VEGF/TKIs and TACE in uHCC: a meta-analysis. [PDF]

Front Oncol
Kang X, Zhang S, Zhang Q, Tang Z, Ji J, Ni M, Wang L.   +6 more
europepmc   +1 more source

Quantitative Hepatobiliary Phase Signal Analysis of HCC Nodules on Gd-EOB-DTPA-Enhanced MRI: A Potential Imaging Biomarker Associated with Disease Control After Conventional Transarterial Chemoembolization (cTACE). [PDF]

J Clin Med
Brandi N, Yakovleva S, Biselli M, Cucchetti A, Bisulli M, Ierardi AM, Mosconi C, Giampalma E, Renzulli M.   +8 more
europepmc   +1 more source

Editorial: Hepatocellular carcinoma: from bench to bedside. [PDF]

Front Genet
İşcan E, Koenig AB, Wu X.
europepmc   +1 more source

Transarterial Chemoembolization Versus Transarterial Radioembolization in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trial Evidence. [PDF]

Cancers (Basel)
Gogna P, Wang C, Underwood D, Farid-Kapadia M, Dasari M, Pyne T, Sinha N, Stirnadel-Farrant HA, Valerio SJ.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Transarterial Chemoembolization and Radioembolization

Seminars in Liver Disease, 2014
Transarterial chemoembolization (TACE) and radioembolization (RE) are frequently used to treat patients with hepatocellular carcinoma who cannot receive curative therapies. Transarterial chemoembolization is a heterogeneous group of procedures; based on two positive clinical trials and three meta-analyses, conventional TACE is the standard of care for ...
Riad Salem, Bruno Sangro
exaly   +3 more sources

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial

Journal of Hepatology, 1998
Background/Aims: Lipiodol chemoembolization is a widely used method of treatment in patients with unresectable hepatocellular carcinoma, but its efficacy is still debated.
Michel Ducreux, Michael Adler, Jean-Pierre Pignon   +2 more
exaly   +2 more sources